UK drug major GSK has entered into a ‘strategic partnership’ with MaRS Innovation, a Canadian group focused on harnessing the commercial potential of the discovery pipelines of 16 top Toronto academic institutions in its network.
Double-digit growth in the Chinese pharmaceutical sector will increasingly make the nation a lucrative place for Western companies to do business, delegates heard at the InterPhex trade event in New York.
Malgorzata Szerszeniewska, CEO of Central and Eastern Europe’s (CEE) “newest” CRO EastHorn, says maintaining ethical standards is crucial to sustaining the rapid patient recruitment rates that characterise the region.
Contract research organisation Bio-Imaging Technologies has decided to sell off its CapMed subsidiary in order to focus its efforts on its core business, providing imaging series to clinical investigators.
The UK launch of Eli Lilly’s pre-filled insulin device Humalog KwikPen offers the country’s 800,000 insulin-dependant diabetics a simplified treatment option, according to company development director Stuart Breslin.
GE Healthcare has announced its intention to invest $20m in radical
new technology, which will allow laboratory research results to be
transmitted and shared amongst doctors worldwide setting to define
a new age in patient care.
In-PharmaTechnologist.com and Outsourcing-Pharma.com journalist
Kirsty Barnes has received the honour of being announced among the
place winners of the 2006 Awards for Excellence in Health Care
The move to make pharmaceutical companies more open to scrutiny has
taken a new direction as the US Food and Drug Administration (FDA)
moves to adopt a system that will allow the electronic coding of
crucial terms used in prescription...
Maxxon are to receive delivery of the first 5,000 batch of its
functional 3 cc Vacuum Operated Retractable Safety Syringe
("ReVac"), which is set to spark a price war amongst fellow
manufacturers in the Safety-engineered...
Companies filing for approval of their drugs in the US market must
now supply all information on the product's labelling and package
insert in an electronic format, according to the Food and Drug
The future of Medisys' Futura safety syringe looked to be in doubt
again yesterday after the company conceded that its timetable for
launch of the safety syringe, originally due for launch in 2001,
had been put back yet again.